MTOR and neoplasm: This process not only enhances the expression of cyclins (Cyclin D1/E) but also stimulates ribosomal biogenesis via activation of the mammalian target of rapamycin (mTOR) pathway, ultimately leading to a significant increase in tumor cell mitotic rates (51, 52).